Molecular cloning of a novel CC chemokine, interleukin-11 receptor α-locus chemokine (ILC), which is located on chromosome 9p13 and a potential homologue of a CC chemokine encoded by molluscum contagiosum virus  by Ishikawa-Mochizuki, Izumi et al.
Molecular cloning of a novel CC chemokine, interleukin-11 receptor
K-locus chemokine (ILC), which is located on chromosome 9p13 and a
potential homologue of a CC chemokine encoded by molluscum
contagiosum virus
Izumi Ishikawa-Mochizukia;1, Motoji Kitauraa;1, Masataka Babaa, Takashi Nakayamab,
Dai Izawab, Toshio Imaib, Hidekazu Yamadac, Kunio Hieshimad, Ryuji Suzukia,
Hisayuki Nomiyamad;2, Osamu Yoshieb;*
aShionogi Institute for Medical Science, Osaka 566-0022, Japan
bDepartment of Microbiology Kinki University School of Medicine, Osaka-Sayama 589-8511, Japan
cDepartment of Dermatology, Kinki University School of Medicine, Osaka-Sayama 589-8511, Japan
dDepartment of Biochemistry, Kumamoto University School of Medicine, Kumamoto 860-0811, Japan
Received 30 September 1999
Abstract Molluscum contagiosum virus (MCV) encodes a CC
chemokine MC148R which is likely to have been acquired from
the host. By a homology search employing MC148R as a probe,
we have identified a novel CC chemokine whose gene exists next
to the IL-11 receptor K (IL-11RK) gene in both humans and
mice. Thus, this chemokine maps to chromosome 9p13 in humans
where IL-11RK has been assigned. We term this novel chemokine
IL-11RK-locus chemokine (ILC). ILC has the highest homology
to MC148R among the known human CC chemokines.
Furthermore, ILC is strongly and selectively expressed in the
skin where infection of MCV also takes place. Thus, ILC is
likely to be the original chemokine of MC148R.
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1. Introduction
Chemokines are small (V8 kDa), structurally related,
mostly basic, heparin binding chemotactic cytokines that
play important roles in the in£ammatory and immunological
responses primarily by inducing emigration of leukocytes and
lymphocytes [1^3]. In humans, over 40 members have been
identi¢ed. Based on the arrangement of the ¢rst two of the
four conserved cysteine residues, the chemokines are divided
into two major subfamilies, the CXC and CC ones. Further-
more, the molecules now representing the C and CX3C sub-
families have been identi¢ed [2,3]. Leukocytes respond to che-
mokines through seven-transmembrane G protein-coupled
receptors [4]. HIV and SIV exploit certain chemokine recep-
tors as coreceptors essential for their entry into target cells
after binding to CD4 [5]. Furthermore, certain viruses such as
herpesviruses encode chemokines and/or chemokine receptors
which are considered to have been acquired from the host and
to facilitate their in vivo growth by modulating host immune
responses [6].
Molluscum contagiosum virus (MCV) is a poxvirus which
infects young children and sexually active adults to causes
benign proliferative lesions of the skin (3^5-mm papules)
that last for months to years before spontaneous regression.
MCV infection typically elicits only a weak immune response
and almost no in£ammatory reaction around the hyperplastic,
virus-¢lled epidermal lesions [7]. There are at least two
types of MCV, MCV-1 and MCV-2, based on restriction en-
donuclease cleavage patterns of viral DNA [8]. Analysis of the
complete genome sequence of MCV-1 has revealed a 104-ami-
no acid open reading frame (MC148R) that is structurally
related to the CC subfamily of chemokines [9]. The chemokine
homologues from MCV-1 and MCV-2 were expressed and
were found to have no chemotactic activity on monocytes
but to block the response of monocytes to macrophage in-
£ammatory protein (MIP)-1K [10]. Consistent with the ab-
sence of chemoattractant activity and the role as a cellular
chemokine antagonist, the chemokine homologues of MCV
have a deletion in the amino-terminal activation domain
[11]. MC148R is considered to have been derived from a
CC chemokine of the host but the host homologue of
MC148R has not been identi¢ed. Here we report a novel
CC chemokine, interleukin-11 receptor K-locus chemokine
(ILC), which is a potential homologue of MC148R.
2. Materials and methods
2.1. Identi¢cation of mouse and human ILC
Using the amino acid sequence of the MCV-1 CC chemokine ho-
mologue MC148R1 [9] as a probe, we searched the public database of
expressed sequence tags (EST) with the BLAST program and identi-
¢ed two murine ESTs potentially encoding a novel CC chemokine
(W10954 from mouse embryo day 19.5; AA024054 from mouse pla-
centa). These clones were obtained and sequenced. The determined
cDNA sequence encoding a novel mouse CC chemokine (mILC) has
been deposited in the DDBJ/GenBank/EBI Data Bank (accession
number AB013398). Using the mouse cDNA as a probe, we next
identi¢ed the mouse genomic clone containing this novel chemokine
gene (GenBank accession number X94161). By analyzing the genomic
sequence, we found that the chemokine gene is located in the very
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close vicinity of the IL-11 receptor K (IL-11RK) gene in a tail-to-tail
orientation. Taking advantage of this information, we ¢rst identi¢ed
the human genomic sequence containing the IL-11RK gene (GenBank
accession number U32323) and analyzed the adjacent sequence with
the gene-predicting program GenScan. We identi¢ed exons 2 and 3 of
a CC chemokine-like gene located close to the human IL-11RK gene.
We then determined the full-length cDNA sequence by the method of
rapid ampli¢cation of cDNA ends (RACE) [12]. In brief, two-step
polymerase chain reaction (PCR) was carried out using human thy-
mus Marathon-Ready cDNA (Clontech) as template. The ¢rst step
PCR was carried out with the ¢rst gene-speci¢c primers (5P-RACE
primer, 5P-TGGGCAGAGTCCCATGGAGCTTTCT-3P ; 3P-RACE
primer, 5P-TTCCTACTGCCACCCAGCACTGCCT-3P) and AP1
primer which is complementary to the adapter ligated at both ends of
cDNA. Then, the second step PCR was carried out using the second
gene-speci¢c primers (5P-RACE primer, 5P-CACTGTGACAGGC-
TGGGGTTCTGGG-3P ; 3P-RACE primer, 5P-CCAGGTGGAACTG-
CAGGAGGCTGAC-3P) and AP2 primer which is also complemen-
tary to the adapter ligated at both ends of cDNA. The ampli¢cation
products were cloned into the pGEM-T Easy vector (Promega) by T-
A ligation and sequenced on both strands. The full-length cDNA
sequence of human ILC has been deposited in the DDBJ/GenBank/
EBI Data Bank (accession number AB010445).
2.2. Expression analysis
Total RNA samples were prepared from various tissues of normal
BALB/c mice and normal human skin tissues by using Trizol reagent
(Gibco-BRL). RNA samples were further puri¢ed by using RNeasy
(Qiagen). Human neonatal epidermal keratinocytes were purchased
from Clonetics (Iwaki Glass, Japan). Total RNA samples were pre-
pared from keratinocytes that were treated without or with lipopoly-
saccharide from Escherichia coli (Sigma), IL-1K, interferon-Q (IFN-Q),
tumor necrosis factor-K (TNF-K), and IL-4 (all purchased from Pe-
proTech), singly or in combination, for 24 h. Multi-tissue Northern
blot ¢lters were purchased from Clontech. Northern blot analysis was
carried out as described previously [13]. RT-PCR was carried out as
follows. Total RNA samples (290 ng each) were reverse transcribed by
using 6 pmol of oligo(dT)18 primer and SuperScript II reverse tran-
scriptase (Gibco-BRL). The resulting ¢rst-strand DNA (15 ng of total
RNA equivalent) and original total RNA (15 ng) were subjected to
PCR ampli¢cation in a ¢nal volume of 20 Wl containing 10 pmol of
each primer and 1 unit of Ex-Taq polymerase (Takara, Japan). The
primers used were: +5P-CCATTTTCCTTAGCATCCCA-3P and
35P-GGACCTTTCTCTACCCAGGC-3P for human ILC and +GCC-
AAGGTCATCCATGACAACTTTGG-3P and 35P-GCCTGCTTC-
zACCACCTTCTTGATGTC-3P for glyceraldehyde 3-phosphate de-
hydrogenase (G3PDH). Ampli¢cation conditions were 94‡C for
5 min, 32 cycles (for ILC) or 27 cycles (for G3PDH) of 94‡C for
30 s, 60‡C for 30 s and 72‡C for 30 s, and ¢nally 72‡C for 5 min.
Ampli¢cation products (6 Wl each) were separated by electrophoresis
on 2% agarose and stained with ethidium bromide.
2.3. Production of recombinant human ILC
Recombinant human ILC was produced as a fusion protein
with the Flag tag as described previously [14]. In brief, the open
reading frame of human ILC fused with the coding sequence of the
Flag tag was subcloned into pDREF-Hyg [15] to generate pDREF-
ILC-Flag (see Fig. 4A). 293/EBNA-1 cells (Invitrogen) were trans-
fected with pDREF-ILC-Flag using Lipofectamine (Gibco-BRL).
After 3^4 days of culture, ILC-Flag secreted in the culture superna-
tant was puri¢ed by using anti-FLAG M2 a⁄nity gel (Kodak) and
reverse phase high performance liquid chromatography (HPLC) es-
sentially as described previously [14]. For immunoblot analysis,
samples were electrophoresed on SDS-PAGE (15^25% gradient)
and electrophoretically transferred onto a ¢lter. The ¢lter was incu-
bated with mouse monoclonal anti-Flag and horseradish peroxidase
(HRP)-labeled goat anti-mouse IgG in succession. The HRP enzy-
matic activity was detected by chemiluminescence using ECL kit
(Amersham).
2.4. Functional assays
L1.2 murine pre-B cells stably expressing CCR1, CCR2b, CCR3,
CCR4, CCR5, CCR6, CCR7, CCR10, XCR1, and CX3CR1 were
described previously [16]. Chemotaxis and calcium £ux assays were
carried out as described previously [14].
3. Results
3.1. Identi¢cation of a mouse novel CC chemokine
MCV, which is a human poxvirus causing benign prolifer-
ative lesions of the skin [7], encodes a 104-amino acid open
reading frame (MC148R) that is structurally related to the CC
subfamily of chemokines [9^11]. It is probable that MCV
acquired the gene from the human host and extensively re-
modeled it during the viral evolution to employ it to evade
host immune responses. Therefore, we wished to identify its
mammalian homologue and to understand the structural and
functional relationship between the original host chemokine
and its MCV version. Using the amino acid sequence of
MC148R1 [9] as a probe, we searched the public EST data-
base for homologous sequences. We found mouse ESTs,
W10954 (from mouse embryo day 19.5) and AA024054
(from mouse placenta) that potentially encoded a novel CC
chemokine. These clones were obtained and sequenced. The
cDNA sequence thus determined contains an open reading
frame that has an in-frame stop codon in the upstream and
encodes a polypeptide of 120 amino acids (indicated as mILC
in Fig. 1B). The amino-terminal region is highly hydrophobic
and likely to be a signal peptide with a potential cleavage site
between Ala-25 and Leu-26. The putative mature protein,
which is a CC chemokine with a distant homology to other
murine CC chemokines, consists of 95 amino acids with a
calculated molecular weight of 10 937 and pI of 11.94. We
searched the GenBank using the cDNA as a probe and found
that the gene was located just in the downstream of the mouse
IL-11RK gene [17] in a tail-to-tail orientation. We call this
novel chemokine murine ILC (mILC) for the reason described
below.
3.2. Tissue expression of mILC
By Northern blot hybridization, we examined the expres-
sion of mILC in various organs of normal mice. As shown in
Fig. 2A, a strong signal of about 1 kb was observed only in
the skin. We also observed weak signals in the brain and testis
using a commercial multiple tissue blot ¢lter (data not
shown). These tissues also contained transcripts of larger sizes
that might be due to alternative splicing or di¡erential poly-
adenylation signals. Thus, mILC appeared to be constitutively
and selectively expressed in the normal skin at high levels.
3.3. Isolation of the human cDNA
There were no human EST sequences homologous to
mILC. Since the mouse gene was found to be located very
close to the IL-11RK gene with a space of only a few nucleo-
tides, we speculated that this might be also true for the human
counterpart. Therefore, we searched a chemokine gene in the
human genomic sequence (GenBank, U32323) that contained
the IL-11RK gene [18,19]. We indeed found exons potentially
encoding a novel CC chemokine in a tail-to-tail arrangement
with the IL-11RK gene with a space only a few nucleotides
(Fig. 3). Based on the exon sequences, we generated speci¢c
primers and carried out 5P- and 3P-RACE [12] using a human
thymus cDNA library. As shown in Fig. 1A, the full-length
cDNA thus determined contains an open reading frame of 112
amino acids. The amino-terminal region is estimated to be a
signal peptide with the probable cleavage site between Ala-24
and Phe-25. The mature protein is a CC chemokine with 88
amino acids with a calculated molecular weight of 10 150 and
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pI of 10.33. Since both human and mouse genes for this novel
chemokine are located in close vicinity to the IL-11RK gene,
we have termed this novel chemokine interleukin-11 receptor
K-locus chemokine (ILC) (mILC for the murine counterpart).
Its systemic nomenclature and gene symbol are CCL27
(mCCL27 for the murine counterpart) and SCYA27, respec-
tively. The human IL-11RK gene has been mapped to chro-
mosome 9p13 [18,19].
3.4. Amino acid alignment
The human and mouse ILC amino acid sequences are
aligned with other chemokines in Fig. 1B. The human and
mouse proteins show the highest homology among the known
CC chemokines with 60.2% identity (mature proteins). The
amino acid sequence of human ILC is only remotely related
to other human CC chemokines with identities below 20%. In
fact, the human ILC sequence has the highest homology to
MC148R1 and MC148R2 from MCV subtypes 1 and 2, re-
spectively [10,11]. Notably, these four chemokines (ILC,
mILC, MC148R1 and MC148R2) also share two extra re-
gions consisting of three amino acids (V/M-E/D-L/Y) and
four amino acids (S-L-S/A/L-Q/R/D) that are not seen in oth-
er chemokines. The phylogenetic tree of the human CC che-
mokines with MC148R1 and MC148R2 also supports that
Fig. 1. A: The nucleotide and deduced amino acid sequences of human ILC. The signal peptide cleavage site is indicated by an arrow. The
polyadenylation signal is underlined. B: Amino acid alignment. The signal peptide sequences are underlined. Four conserved cysteine residues
are boxed. The % amino acid identity between human ILC and each indicated chemokine is shown in the right. Percent identity between ma-
ture proteins is shown in parentheses. MC148R1 and MC148R2 are the CC chemokine homologues encoded by MCV subtypes 1 and 2, respec-
tively [10,11]. ELC, EBI1-ligand chemokine; TECK, thymus-expressed chemokine; LARC, liver and activation-regulated chemokine; MCP-1,
monocyte chemotactic protein 1; MIP-1K, macrophage in£ammatory protein 1K. C: Phylogenetic tree of the human CC chemokines with
MCV chemokines (MC148R1 and MC148R2). Evolutionary distance was estimated using the prrp and phylp programs [21]. The chromosome
on which each chemokine has been mapped is indicated on the right.
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ILC and MC148R were diverged from a common ancestor
(Fig. 1C).
3.5. Tissue expression of ILC
By Northern blot hybridization using a commercially avail-
able ¢lter (Clontech), the expression of ILC in various human
organs was examined. A weak signal of about 0.8 kb was
detected in the thymus and placenta (data not shown). We
also examined the expression of ILC by PCR using multiple
tissue cDNA panels (Clontech). ILC expression was detected
in thymus, placenta, testis and ovary (data not shown). Since
these commercial samples did not contain skin samples, we
separately examined the expression of ILC in normal human
skin tissues by RT-PCR. As shown in Fig. 2B, ILC transcripts
were consistently detected in normal human skin tissues.
However, human neonatal epidermal keratinocytes cultured
and treated without or with LPS, IL-1K, IFN-Q, TNF-K and
IL-4 alone or in combination for 24 h did not express ILC at
levels detectable by RT-PCR (data not shown).
3.6. Production of recombinant ILC and functional analysis
293/EBNA-1 cells were transfected with an expression vec-
tor for human ILC fused with a Flag tag [14] and culture
supernatants were analyzed by immunoblot using anti-Flag.
As shown in Fig. 4B, ILC-Flag was secreted in the culture
supernatant. We therefore puri¢ed ILC-Flag from the culture
supernatant by anti-Flag a⁄nity gel and HPLC. ILC-Flag
was eluted as a single peak from HPLC and migrated as a
single band of 12 kDa on SDS-PAGE (not shown). The ami-
no acid sequencing analysis revealed that the amino-terminus
of the mature secreted protein was 25F-L-L-P-P-S as expected.
We examined the biological activity of recombinant ILC-
Flag using murine L1.2 cells stably transfected with CCR1,
CCR2b, CCR3, CCR4, CCR5, CCR6, CCR7, CCR10,
XCR1, and CX3CR1 [16]. ILC-Flag failed to induce any che-
motactic or calcium £ux responses in these panel of chemo-
kine receptor-expressing L1.2 cells even though the chemo-
kines used as positive controls for the respective receptors
induced vigorous responses (data not shown). Furthermore,
ILC-Flag at a 10-fold excess did not show any inhibitory
e¡ect on the activities of the chemokines acting on these re-
ceptors in calcium £ux assays. ILC-Flag also failed to induce
any signi¢cant migration of peripheral blood mononuclear
cells in a transendothelial migration assay [14].
4. Discussion
We have identi¢ed a novel CC chemokine ILC whose gene
exists in close conjunction with the IL-11RK gene in a tail-to-
tail orientation with a space of a few nucleotides in both
human and mouse (Fig. 3). Importantly, the human IL-
11RK gene has been mapped to chromosome 9p13 [18,19]
where two CC chemokines, secondary lymphoid-tissue chemo-
kine (SLC) and EBI1-ligand chemokine (ELC), are also as-
signed [3]. Indeed, we have evidence that these three CC che-
mokines exist within 200 kb. Thus, ILC, SLC and ELC exist
in a minicluster of chemokine genes at chromosome 9p13.
SLC and ELC share CCR7 and have overlapping biological
functions [3]. This suggests that SLC and ELC have diverged
from a common ancestor. ILC may have derived from the
same ancestor but may have diverged further to act on a
distinct receptor.
ILC is likely to be the homologue of the MCV encoded
chemokine MC148R since (1) ILC has the highest homology
Fig. 2. Expression analysis. A: Northern blot analysis of mILC in
normal mouse tissues. 1, uterus; 2, ovary; 3, bone marrow; 4,
lymph node; 5, thymus; 6, spleen; 7, skin; 8, skeletal muscle; 9, co-
lon; 10, small intestine; 11, stomach; 12, kidney; 13, liver; 14,
lung; 15, heart; 16, brain. The size markers are shown on the left.
B: RT-PCR analysis of human ILC expression in the skin. 1, no
templates; 2, PHA-activated PBMC; 3^5, normal human skin tis-
sues.
Fig. 3. The physical arrangement of the human ILC and IL-11 receptor K genes. The arrows indicate transcriptional orientation. The closed
boxes indicate the exons of the ILC gene. The hatched boxes indicate the exons of the IL-11RK gene. The genomic sequence, the 3P-end of
ILC cDNA and the 3P-end of IL-11RK cDNA are aligned in the bottom. The small letters, a or t, at the 3P ends of the cDNAs indicate the
poly(A) sequences.
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to MC148R, (2) ILC shares with MC148R two regions of a
few extra amino acids not seen in other chemokines, (3) ILC
and MC148R have the closest relationship in the phylogenetic
tree, and (4) ILC is strongly expressed in the skin where in-
fection and replication of MCV also take place. Thus, ILC
may be applicable to antagonize the MCV chemokine for
therapeutic purposes.
ILC failed to induce any responses in a panel of L1.2 cells
expressing various cloned chemokine receptors. At present,
therefore, we do not know the biological activity of ILC. Its
strong and selective expression in the skin may indicate that
some migratory cells unique to the skin are the targets of ILC.
We did not detect expression of ILC in normal epidermal
keratinocytes without or with stimulation by various cyto-
kines. Thus, the tissue cells expressing ILC also remain to
be identi¢ed.
During the ¢nal stage of this work, Hromas et al. [20]
reported a novel murine CC chemokine termed ALP for its
amino-terminal peptide sequence. ALP is identical to mILC.
ALP was shown to be expressed in the heart, liver and testis.
The skin was not examined. In transwell chemotaxis assays,
ALP did not show any chemotactic activity for bone marrow
granulocytes or monocytes, T cells from the thymus, or B cells
or T cells from the spleen [20].
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Fig. 4. Production of recombinant ILC. A: The physical map of the
expression vector pDREF-ILC-Flag. The open reading frame encod-
ing ILC fused to Flag tag [14] was inserted under the control of the
EF-1K promoter as indicated. B: Detection of ILC-Flag by immu-
noblotting. Culture supernatants from 293/EBNA-1 cells transfected
with pDREF-Hyg (3) or pDREF-ILC-Flag (+) were electrophor-
esed on SDS-polyacrylamide gel (15^25% gradient) and transferred
to a ¢lter. ILC-Flag was detected by immunoblotting. Size markers
are shown on the left.
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